Urinary gonadotrophins but not recombinant gonadotrophins reduce expression of VEGF120 and its receptors flt-1 and flk-1 in the mouse uterus during the peri-implantation period.
暂无分享,去创建一个
[1] E. Karteris,et al. Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. , 2004, Journal of molecular endocrinology.
[2] M. Keirse,et al. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004 .
[3] I. Cameron,et al. Ovulation induction/intrauterine insemination in infertile couples is associated with low-birth-weight infants. , 2003, American Journal of Obstetrics and Gynecology.
[4] M. Gassmann,et al. Expression of Hypoxia-inducible Factors in the Peri-implantation Mouse Uterus Is Regulated in a Cell-specific and Ovarian Steroid Hormone-dependent Manner , 2003, The Journal of Biological Chemistry.
[5] R. Koos,et al. Inhibition of Vascular Endothelial Growth Factor/Vascular Permeability Factor Action Blocks Estrogen-Induced Uterine Edema and Implantation in Rodents1 , 2002, Biology of reproduction.
[6] E. D. de Kloet,et al. Gonadotrophin stimulation reduces VEGF(120) expression in the mouse uterus during the peri-implantation period. , 2002, Human reproduction.
[7] S. Dey,et al. Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. , 2001, Molecular endocrinology.
[8] G. Coukos,et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance , 2001, Nature Immunology.
[9] P. Rogers,et al. Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. , 2001, Reproduction.
[10] T. D’Hooghe,et al. Superovulation of female mice delays embryonic and fetal development. , 2001, Human reproduction.
[11] S. Soker,et al. Differential expression of VEGF isoforms and VEGF164‐specific receptor neuropilin‐1 in the mouse uterus suggests a role for VEGF164 in vascular permeability and angiogenesis during implantation , 2000, Genesis.
[12] D. Valbuena,et al. Ovarian stimulation and endometrial receptivity. , 1999, Human reproduction.
[13] I. Aifantis,et al. Expression of corticotrophin-releasing hormone in the mouse uterus: participation in embryo implantation. , 1999, The Journal of endocrinology.
[14] R. Pijnenborg,et al. The influence of in-vitro culture versus stimulated and untreated oviductal environment on mouse embryo development and implantation. , 1999, Human reproduction.
[15] S. Kaul,et al. A Novel Alternatively Spliced Form of Murine Vascular Endothelial Growth Factor, VEGF 115* , 1998, The Journal of Biological Chemistry.
[16] S. Dey,et al. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. , 1995, The Journal of endocrinology.
[17] C. Stournaras,et al. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. , 1995, Life sciences.
[18] A. Romeu,et al. Effect of recombinant human luteinizing hormone versus human chorionic gonadotrophin: effects on ovulation, embryo quality and transport, steroid balance and implantation in rabbits. , 1995, Human reproduction.
[19] A. Romeu,et al. Recombinant hormones: Effect of recombinant human luteinizing hormone versus human chorionic gonadotrophin: effects on ovulation, embryo quality and transport, steroid balance and implantation in rabbits , 1995 .
[20] F. Helmerhorst,et al. Follow-up of 30 pregnancies after embryo cryopreservation. , 1995, European journal of obstetrics, gynecology, and reproductive biology.
[21] H. Phillips,et al. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. , 1993, Endocrinology.
[22] R. Frydman,et al. Pregnancy: The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself , 1993 .
[23] R. de Leeuw,et al. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. , 1993, Fertility and sterility.
[24] T. Lyberg,et al. Treatment with gonadotropins impaired implantation and fetal development in mice , 1993, Journal of Assisted Reproduction and Genetics.
[25] G. Ertzeid,et al. Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. , 1992, Journal of reproduction and fertility.
[26] G. Breier,et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.
[27] C. O'neill,et al. Elevated luteal phase estradiol:progesterone ratio in mice causes implantation failure by creating a uterine environment that suppresses embryonic metabolism. , 1990, Fertility and sterility.
[28] D. Connolly,et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.
[29] C. O'neill,et al. Failure of implantation in human in vitro fertilization and embryo transfer patients: The effects of altered progesterone/ estrogen ratios in humans and mice , 1987, Fertility and sterility.
[30] Y. Yun,et al. Effects of superovulatory doses of pregnant mare serum gonadotropin on oocyte quality and ovulatory and steroid hormone responses in rats. , 1987, Gamete research.
[31] D. Armstrong,et al. Effects of a superovulatory dose of pregnant mare serum gonadotropin on ovarian function, serum estradiol, and progesterone levels and early embryo development in immature rats. , 1981, Biology of reproduction.
[32] B. Nisula,et al. Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans. , 1980, The Journal of clinical endocrinology and metabolism.
[33] A. Enders,et al. A morphological analysis of the early implantation stages in the rat , 1967 .
[34] A. Romeu,et al. Recombinant-human luteinizing hormone (r-hLH) as ovulatory stimulus in superovulated does , 2005, Journal of Assisted Reproduction and Genetics.
[35] K. L. Moore,et al. The developing human , 1988 .
[36] W. J. Silvia,et al. Differences in the lateral mobility of receptors for luteinizing hormone (LH) in the luteal cell plasma membrane when occupied by ovine LH versus human chorionic gonadotropin. , 1985, Endocrinology.
[37] A. Psychoyos. Hormonal control of ovoimplantation. , 1973, Vitamins and hormones.